Last edition
News about "Series B financing"
Alphyn Closes USD 25 Million Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
Alphyn has closed an oversubscribed USD 25 million Series B financing round to support its dermatology pipeline, including a global Phase II (b) trial in atopic dermatitis and a Phase II clinical programme in molluscum contagiosum.
Series B Financing | 16/12/2025 | By News Bureau
D3 Bio Secures USD 108 Million in Series B Financing to Advance Global Clinical Programmes
D3 Bio has raised USD 108 million in Series B financing to advance its global clinical programmes. The funds will support the Phase III pivotal trial of its lead asset, elisrasib (D3S-001), while also accelerating the development of the company’s broader pipeline of targeted and immuno-oncology therapies with first-in-class and best-in-class potential.
Series B Financing | 11/12/2025 | By Akanki
AusperBio Bags USD 73 Million in Series B Financing for Chronic Hepatitis B
This financing followed the company's Series A round completed in July this year, demonstrating continued investor confidence in its proprietary platform and strategic direction.
Series B Financing | 27/12/2024 | By Aishwarya | 176
Vicebio Raises USD 100 Million in Series B Financing Round
Vicebio is developing next-generation vaccines for respiratory viruses utilising its proprietary Molecular Clamp technology, discovered at The University of Queensland.
Series B Financing | 23/09/2024 | By Aishwarya | 421
iOnctura Secures EUR 80 Million in Series B Financing Round
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, has closed a EUR 80 million Series B financing.
Series B Financing | 21/06/2024 | By Aishwarya | 602
LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Series B Financing | 23/05/2024 | By Aishwarya | 612
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy